HUB Organoids as a New Diagnostic Platform to Improve Cancer Patient Treatment
Time: 2:20 pm
day: Day One
Details:
- How to generate unique clinically relevant patient-derived models using HUB Organoid Technology
- HUB Organoids capture tumour heterogeneity and preserve tumour genetic make-up and pathology
- Published clinical data have shown that HUB Organoids mimic patient response
- The use of an organoid-based platform for drug screening, patient stratification, and personalised medicine approaches
